Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Anti-Infective Agents
/ chemical synthesis
Antineoplastic Agents
/ chemical synthesis
Drug Design
Escherichia coli
/ drug effects
Fungi
/ drug effects
Gram-Positive Bacterial Infections
/ drug therapy
HCT116 Cells
Hep G2 Cells
Humans
MCF-7 Cells
Molecular Docking Simulation
Mycoses
/ drug therapy
Neoplasms
/ drug therapy
Pyrimidines
/ chemical synthesis
Staphylococcus aureus
/ drug effects
Antimicrobial
Barbituric acid
Cytotoxic activities
DNA intercalators
Pyranopyrimidine derivatives
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
20
04
2021
revised:
28
06
2021
accepted:
14
07
2021
pubmed:
28
7
2021
medline:
18
12
2021
entrez:
27
7
2021
Statut:
ppublish
Résumé
Pyrano[2,3-d]pyrimidine derivatives were synthesized by treating cyclic compounds containing active methylene group with aldehyde and malononitrile in butanol. The behavior of pyrano[2,3-d]pyrimidine towards some electrophlies namely triethylorthoformate followed by nitrogen nucleophiles as isobutylamine, urea, phenylthiourea, p-toluidine, o-phenylenediamine, o-aminophenol, 2-amino-4-methyl-pyridine and acetic acid with the aim of obtaining some interesting non-mixed heterocyclic compounds. All synthesized compounds to some extent have shown good antimicrobial activity against different microbial strains that had been extracted by inhibiting cell wall synthesis. Compound 5b showed the highest antibacterial activities against B. subtilis, S. aureus and E. coli. On the other hand compound 5 g exhibited the highest antibacterial and antifungal activities against P. aeruginosa and A. niger respectively. In addition, they explore cytotoxic potentialities against different cell lines via DNA intercalation and Top-II inhibition. The cytotoxic activities clarify the strong inhibitory activity of derivative 5a against HepG2 cells with IC
Identifiants
pubmed: 34314914
pii: S0045-2068(21)00563-0
doi: 10.1016/j.bioorg.2021.105186
pii:
doi:
Substances chimiques
Anti-Infective Agents
0
Antineoplastic Agents
0
Pyrimidines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105186Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.